Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women
- 1 January 2003
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (2) , 252-254
- https://doi.org/10.1016/s0002-9149(02)03121-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Hormone replacement therapy: Estrogen and progestin effects on plasma C-reactive protein concentrationsAmerican Journal of Obstetrics and Gynecology, 2002
- Effect of Medroxyprogesterone Acetate on Vascular Inflammatory Markers in Postmenopausal Women Receiving EstrogenCirculation, 2002
- The Effects of Varying Doses of T on Insulin Sensitivity, Plasma Lipids, Apolipoproteins, and C-Reactive Protein in Healthy Young MenJournal of Clinical Endocrinology & Metabolism, 2002
- Differential Effects of E and Droloxifene on C-Reactive Protein and Other Markers of Inflammation in Healthy Postmenopausal WomenJournal of Clinical Endocrinology & Metabolism, 2001
- Novel Risk Factors for Systemic AtherosclerosisJAMA, 2001
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Effect of Postmenopausal Hormones on Inflammation-Sensitive ProteinsCirculation, 1999
- C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged MenCirculation, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998